Drug Shortage Report for ROPIVACAINE HYDROCHLORIDE INJECTION, USP

Last updated on 2020-04-25 History
Report ID 111239
Drug Identification Number 02439379
Brand name ROPIVACAINE HYDROCHLORIDE INJECTION, USP
Common or Proper name Ropivacaine Hydrochloride Injection, USP, 2 mg/mL freeflex® Bag 100 mL
Company Name FRESENIUS KABI CANADA LTD
Market Status MARKETED
Active Ingredient(s) ROPIVACAINE HYDROCHLORIDE
Strength(s) 2MG
Dosage form(s) SOLUTION
Route of administration EPIDURAL INFILTRATION INFILTRATION EPIDURAL
Packaging size 100 mL
ATC code N01BB
ATC description ANESTHETICS, LOCAL
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2020-04-01
Actual start date 2020-04-01
Estimated end date 2020-04-20
Actual end date 2020-04-24
Shortage status Resolved
Updated date 2020-04-25
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 165 GALAXY BLVD, SUITE 100
TORONTO, ONTARIO
CANADA M9W 0C8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2020-04-25 English Compare
v4 2020-04-22 French Compare
v3 2020-04-22 English Compare
v2 2020-04-07 French Compare
v1 2020-04-07 English Compare

Showing 1 to 5 of 5